https://ipharmag.com/article/osteoporosis-drug-development-reinvigorated-interest iPharmag en 2026-09-23T16:00:57+00:00 After Years of Neglect, Osteoporosis Drugs Are Suddenly Hot Again https://ipharmag.com/article/europe-biotech-decline-pharma-chairs-alarm iPharmag en 2026-09-23T16:00:57+00:00 Nine Pharma Chairs Warn Europe Is Losing the Biotech Race https://ipharmag.com/article/boomray-novartis-900m-radioligand-therapy-deal iPharmag en 2026-09-23T16:00:57+00:00 Novartis Pays Up to $900M for a Chinese Biotech’s Radioactive Cancer Drug https://ipharmag.com/article/boehringer-envisagenics-1-billion-rna-splicing-cancer-ai iPharmag en 2026-09-23T16:00:57+00:00 Boehringer Bets Over $1B on AI That Reads a Hidden Layer of Cancer Biology https://ipharmag.com/article/basecamp-research-140m-ai-designed-drugs-eden iPharmag en 2026-09-23T16:00:57+00:00 Anthropic- and Nvidia-Backed Startup Raises $140M to Let AI Design Living Medicines